A retrospective multicenter study to determine real-world outcomes in patients with relapsed/refractory multiple myeloma receiving daratumumab monotherapy
Latest Information Update: 19 Aug 2021
At a glance
- Drugs Daratumumab (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 19 Aug 2021 New trial record